• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫活性宿主心肌梗死后诱导多能干细胞的心脏肿瘤形成潜能。

Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction.

机构信息

Department of Pathology, University of Cincinnati, Cincinnati, OH 45267-0529, USA.

出版信息

Regen Med. 2011 Mar;6(2):171-8. doi: 10.2217/rme.10.103.

DOI:10.2217/rme.10.103
PMID:21391851
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3110348/
Abstract

AIM

Genetic reprogramming of somatic cells with stemness genes to restore their pluripotent status is being studied extensively to generate pluripotent stem cells as an alternative to embryonic stem cells. This study was designed to examine the effectiveness of skeletal myoblast-derived induced pluripotent stem cells (SkiPS) from young male Oct4/GFP transgenic mice for regeneration of the infarcted heart.

METHODS & RESULTS: A mouse model of permanent coronary artery ligation was developed in young female immunocompetent C57BL/6J or C57BL/6x129S4 SV/jae Oct4/GFP mice. SkiPS labeled with Q-dots (3 × 10(5) in 10 µl basal Dulbecco's modified Eagle's medium) were transplanted in and around the area of infarct immediately after coronary artery ligation (n = 16) under direct vision. Control mice (n = 12) were injected with the same number of skeletal myoblasts. Histological studies documented successful engraftment of SkiPS in all the surviving animals 4 weeks later. However, six of the 16 SkiPS-transplanted (37.5%) animal hearts showed intramural teratomas, whereas no tumor growth was observed in the control mice. Q-dot-labeled donor cells were also observed at the site of tumors. Histological studies revealed that teratomas were composed of cells from all of the three embryonic germ layers. Ultra-structure studies confirmed the histological findings and showed regions with well-organized myofibrillar structures in the tumors.

CONCLUSION

Undifferentiated induced pluripotent stem cells should not be recommended for cardiac transplantation unless screened for specific teratogenic precursors or predifferentiated into cardiac lineage prior to transplantation.

摘要

目的

通过将干性基因遗传重编程体细胞来恢复其多能性状态,从而产生多能干细胞来替代胚胎干细胞,这一研究正在广泛开展。本研究旨在探讨年轻雄性 Oct4/GFP 转基因小鼠骨骼肌成肌细胞衍生的诱导多能干细胞(SkiPS)在梗死心脏再生中的有效性。

方法与结果

在年轻的雌性免疫功能正常的 C57BL/6J 或 C57BL/6x129S4 SV/jae Oct4/GFP 小鼠中建立了永久性冠状动脉结扎的小鼠模型。在冠状动脉结扎后(n = 16)直视下将 Q-dots 标记的 SkiPS(10 µl 基础 Dulbecco 改良 Eagle 培养基中 3×10(5)个)移植到梗死区及其周围。对照组(n = 12)注射了相同数量的骨骼肌成肌细胞。组织学研究证明,4 周后所有存活动物的 SkiPS 均成功植入。然而,在 16 只 SkiPS 移植的动物心脏中有 6 只(37.5%)出现了壁内畸胎瘤,而对照组动物未观察到肿瘤生长。也在肿瘤部位观察到了 Q-dot 标记的供体细胞。组织学研究显示,畸胎瘤由三个胚层的细胞组成。超微结构研究证实了组织学发现,并显示肿瘤中有组织结构良好的肌原纤维区域。

结论

除非对未分化的诱导多能干细胞进行特定的致畸前体筛查或在移植前预先分化为心脏谱系,否则不建议将其用于心脏移植。

相似文献

1
Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction.免疫活性宿主心肌梗死后诱导多能干细胞的心脏肿瘤形成潜能。
Regen Med. 2011 Mar;6(2):171-8. doi: 10.2217/rme.10.103.
2
Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells.用一种单一的小分子高效地将成肌细胞重编程为干细胞,以生成心脏祖细胞。
PLoS One. 2011;6(8):e23667. doi: 10.1371/journal.pone.0023667. Epub 2011 Aug 17.
3
Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.高效重编程成年骨髓细胞生成诱导多能干细胞。
Stem Cells Dev. 2010 Feb;19(2):229-38. doi: 10.1089/scd.2009.0149.
4
Reprogramming of somatic cells after fusion with induced pluripotent stem cells and nuclear transfer embryonic stem cells.体细胞经诱导多能干细胞融合和核移植胚胎干细胞重编程。
Stem Cells Dev. 2010 Feb;19(2):239-46. doi: 10.1089/scd.2009.0142.
5
Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart.将成肌细胞重编程为多能性细胞以在梗死心脏中诱导无肿瘤的心肌发生。
Circ Res. 2011 Jun 24;109(1):60-70. doi: 10.1161/CIRCRESAHA.110.240010. Epub 2011 May 12.
6
Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells.多能胚胎干细胞治疗后梗死小鼠心脏功能改善。
Anat Rec A Discov Mol Cell Evol Biol. 2006 Nov;288(11):1216-24. doi: 10.1002/ar.a.20388.
7
Derivation and characterization of sleeping beauty transposon-mediated porcine induced pluripotent stem cells.睡眠美人转座子介导的猪诱导多能干细胞的分离与鉴定。
Stem Cells Dev. 2013 Jan 1;22(1):124-35. doi: 10.1089/scd.2012.0382. Epub 2012 Nov 2.
8
Generation of pig iPS cells: a model for cell therapy.猪诱导多能干细胞的生成:细胞治疗的一种模型。
J Cardiovasc Transl Res. 2011 Apr;4(2):121-30. doi: 10.1007/s12265-010-9233-3. Epub 2010 Nov 19.
9
Successful Derivation of an Induced Pluripotent Stem Cell Line from a Genetically Nonpermissive Enhanced Green Fluorescent Protein-Transgenic FVB/N Mouse Strain.从基因非许可的增强型绿色荧光蛋白转基因FVB/N小鼠品系成功诱导出诱导多能干细胞系。
Cell Reprogram. 2019 Oct;21(5):270-284. doi: 10.1089/cell.2019.0019.
10
MyoD gene suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells.肌节同源盒蛋白基因(MyoD)的抑制是 Oct4 在成肌细胞中重编程为诱导多能干细胞所必需的。
Stem Cells. 2011 Mar;29(3):505-16. doi: 10.1002/stem.598.

引用本文的文献

1
iPSC-derived and Patient-Derived Organoids: Applications and challenges in scalability and reproducibility as pre-clinical models.诱导多能干细胞衍生和患者来源的类器官:作为临床前模型在可扩展性和可重复性方面的应用与挑战。
Curr Res Toxicol. 2024 Oct 2;7:100197. doi: 10.1016/j.crtox.2024.100197. eCollection 2024.
2
Maturation of pluripotent stem cell-derived cardiomyocytes: limitations and challenges from metabolic aspects.多能干细胞源性心肌细胞的成熟:代谢方面的局限性和挑战。
Stem Cell Res Ther. 2024 Oct 8;15(1):354. doi: 10.1186/s13287-024-03961-4.
3
Cell-Based and Selected Cell-Free Therapies for Myocardial Infarction: How Do They Compare to the Current Treatment Options?基于细胞和无细胞的心肌梗死治疗方法:它们与当前的治疗选择相比如何?
Int J Mol Sci. 2022 Sep 7;23(18):10314. doi: 10.3390/ijms231810314.
4
Myocardial infarction from a tissue engineering and regenerative medicine point of view: A comprehensive review on models and treatments.从组织工程与再生医学角度看心肌梗死:关于模型与治疗的全面综述
Biophys Rev (Melville). 2022 Sep;3(3):031305. doi: 10.1063/5.0093399. Epub 2022 Aug 30.
5
Review Insights In Cardiac Tissue Engineering: Cells, Scaffolds, and Pharmacological Agents.心脏组织工程学综述:细胞、支架与药理剂
Iran J Pharm Res. 2021 Fall;20(4):467-496. doi: 10.22037/IJPR.2021.114730.15012.
6
Cardiac Remodeling and Repair: Recent Approaches, Advancements, and Future Perspective.心脏重构与修复:近期方法、进展及未来展望。
Int J Mol Sci. 2021 Dec 3;22(23):13104. doi: 10.3390/ijms222313104.
7
Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes.诱导多能干细胞衍生心肌细胞的成熟策略和限制。
Biosci Rep. 2021 Jun 25;41(6). doi: 10.1042/BSR20200833.
8
Adipose-derived mesenchymal stem cell seeded Atelocollagen scaffolds for cardiac tissue engineering.脂肪间充质干细胞种植于几丁聚糖支架用于心脏组织工程。
J Mater Sci Mater Med. 2020 Sep 23;31(10):83. doi: 10.1007/s10856-020-06425-2.
9
Cardiac repair in a murine model of myocardial infarction with human induced pluripotent stem cell-derived cardiomyocytes.人心肌梗死后的人心诱导多能干细胞源性心肌细胞的心脏修复。
Stem Cell Res Ther. 2020 Jul 17;11(1):297. doi: 10.1186/s13287-020-01811-7.
10
Isolation of adipose tissue derived regenerative cells from human subcutaneous tissue with or without the use of an enzymatic reagent.从人体皮下组织中分离具有或不使用酶试剂的脂肪组织来源的再生细胞。
PLoS One. 2019 Sep 3;14(9):e0221457. doi: 10.1371/journal.pone.0221457. eCollection 2019.

本文引用的文献

1
c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.c-MYC 非依赖性核重编程有利于诱导多能干细胞的心脏生成潜能。
J Cardiovasc Transl Res. 2010 Feb;3(1):13-23. doi: 10.1007/s12265-009-9150-5.
2
Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro.在体外从鼠诱导多能干细胞中分离的心肌细胞的功能特征。
FASEB J. 2009 Dec;23(12):4168-80. doi: 10.1096/fj.08-128546. Epub 2009 Aug 24.
3
Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.人干性因子诱导多能干细胞修复急性心肌梗死
Circulation. 2009 Aug 4;120(5):408-16. doi: 10.1161/CIRCULATIONAHA.109.865154. Epub 2009 Jul 20.
4
Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43.Sca-1+干细胞在梗死心脏中的存活与植入:预处理诱导的连接蛋白43的双重作用
Circulation. 2009 May 19;119(19):2587-96. doi: 10.1161/CIRCULATIONAHA.108.827691. Epub 2009 May 4.
5
The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells.抗凋亡基因survivin有助于人类胚胎干细胞形成畸胎瘤。
Nat Biotechnol. 2009 Mar;27(3):281-7. doi: 10.1038/nbt.1527. Epub 2009 Mar 1.
6
The many ways to make an iPS cell.制造诱导多能干细胞的多种方法。
Nat Biotechnol. 2008 Nov;26(11):1246-8. doi: 10.1038/nbt1108-1246.
7
Induced pluripotent stem cells generated without viral integration.无病毒整合产生的诱导多能干细胞。
Science. 2008 Nov 7;322(5903):945-9. doi: 10.1126/science.1162494. Epub 2008 Sep 25.
8
Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repair.动员的骨髓祖细胞作为心脏修复的细胞保护基因供体。
J Mol Cell Cardiol. 2008 Mar;44(3):607-17. doi: 10.1016/j.yjmcc.2007.11.011. Epub 2007 Dec 7.
9
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.从小鼠和人成纤维细胞中生成不含Myc的诱导多能干细胞。
Nat Biotechnol. 2008 Jan;26(1):101-6. doi: 10.1038/nbt1374. Epub 2007 Nov 30.
10
Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts.人胚胎干细胞衍生心肌细胞的移植改善梗死大鼠心脏的心肌性能。
J Am Coll Cardiol. 2007 Nov 6;50(19):1884-93. doi: 10.1016/j.jacc.2007.07.054. Epub 2007 Oct 23.